Decades of sleep physiology research at University of Toronto leads to new sleep apnea drug showing promise in Phase 3 trial
By
colinprince
9d ago· 4 min readenNews
80/100
Golden Brown
Bagelometer↗
A baker's-dozen of insight crammed into one ring.
Score80TypenewsSentimentpositive
Summary
A University of Toronto professor's decades-long research on the physiology of sleep and breathing has led to a new drug treatment for sleep apnea that recently showed positive results in a Phase 3 clinical trial. The research, which began in the early 1990s, traces back to foundational work in sleep labs in the UK and North America, highlighting how sustained academic research can translate into clinical treatments.
Key quotes
· 2 pulledHorner's journey in sleep research began in the early 90s as a PhD student at the University of London where he worked in one of the first sleep labs in the United Kingdom.
U of T's reputation as a leader in sleep research drew him to the city to pursue a postdoctoral fellowship with Eliot Phillipson, a clinician-scientist at U of T who established one of North America's first human sleep labs in 1978 to study breathing disturbances.
A University of Toronto professor’s research on the physiology of sleep and breathing has paved the way for a new sleep apnea treatment that recently reported positive results in a phase 3 clinical trial.
